CytomX Therapeutics

📍 South San Francisco, United States👥 155 employees💰 Last funded Apr 2020
CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected. We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population. CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category. CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
3
Investor activity2013–2020 · investors recorded per year
201312018120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CytomX Therapeutics?
CytomX Therapeutics has 3 investors on record on gritt.io.
When did CytomX Therapeutics last raise funding?
The most recent investment in CytomX Therapeutics recorded on gritt.io was in April 2020.
What industry is CytomX Therapeutics in?
CytomX Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is CytomX Therapeutics based?
CytomX Therapeutics is headquartered in South San Francisco, United States.